$ENTB news yesterday gaining some traction ....
Post# of 45
Entest BioMedical, Inc. Sees Entry Into $300 Million Veterinary Cancer Care Market Through Veterinary Hospital Acquisitions
Further Veterinary Hospital Acquisitions to Provide Launch Pad for Entest's Growth Model -- Revenue, Therapeutic Animal Drug Distribution & Veterinary Drug Development Focused on Canine Cancer Care
$ENTB potential reversal targets below
ENTB - Entest BioMedical Inc.
Company Overview
Website -